Shankar Balasubramanian

Shankar is the Herchel Smith Professor of Medicinal Chemistry at the University of Cambridge. He is recognised for his research contributions to the chemical biology of nucleic acids and the genome. Shankar was a co-inventor of Solexa sequencing and a founder of Solexa that was subsequently acquired by Illumina Inc. for $600M. His research group is based at the Department of Chemistry and also the Cancer Research UK Cambridge Research Institute. His recent awards include the Royal Society Mullard Award (2009), The BBSRC Innovator of the year (2010) and the Tetrahedron Prize (2013). He is a Fellow of The Royal Society, The Academy of Medical Sciences and a member of EMBO.